Antidepressant-induced sexual dysfunction is a frequent side effect which may greatly contribute to treatment non compliance. Mirtazapine has a pharmacological profile expected to result in a lack of sexual dysfunction. The main purpose of this 6-month open-label study was to evaluate the effects of
Efficacy of mirtazapine in clinically relevant subgroups of depressed patients
β Scribed by D. J. Nutt
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 117 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1091-4269
No coin nor oath required. For personal study only.
β¦ Synopsis
Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA) with a novel mode of action that differs from other antidepressants that are currently available. Clinical trials have demonstrated it to have good antidepressant efficacy and excellent tolerability. Analysis of the results of placebo-controlled trials in moderately or severely depressed patients have shown mirtazapine to be effective in clinically important subgroups of depressed patients, particularly anxious patients, patients with sleep disturbance, retarded patients, and agitated patients. The efficacy and tolerability of mirtazapine are attributable to its pharmacological profile. It is likely that the overall antidepressant activity arises from its dual action, enhancing both noradrenergic and 5-HT 1 receptor-mediated serotonergic neurotransmission, while the anxiolytic and sleep-improving properties of mirtazapine are attributable to the specific blockade of 5-HT 2 and 5-HT 3 receptors. Depression and Anxiety,
Volume 7, Supplement 1:7-10, 1998.
π SIMILAR VOLUMES
A meta-analysis was performed to assess the effectiveness of the novel antidepressant venlafaxine in depressed patients with psychomotor retardation andor agitation [respective baseline item score greater than zero on the Hamilton Rating Scale for Depression (HAM-D)]. Data from five comparable place
## Objective: To investigate the efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia. ## Method: Thirty-nine patients fulfilling dsm-iv-tr diagnostic criteria for schizophrenia and had depressive symptoms were studied in a prospective 6-week open-label design
## Abstract ## Background Indiscriminate removal of axillary nodes may not be justified as it may potentially worsen the morbidity of the sentinel lymph node biopsy (SNB) procedure. This study examined the factors associated with removal of multiple sentinel lymph nodes and determined whether ther
## Abstract ## Background: In DSMβIV anorexics who purge without binging (ANβP) are considered together with the binge eating purging subgroup (ANβB). Few studies have investigated whether it is binge eating __per se__ or the compensatory behaviours that provide the most relevant marker for subcla